Src inhibition is still a relevant target in pancreatic cancer.
作者信息
George Thomas J, Trevino Jose G, Liu Chen
机构信息
Departments of Medicine.
出版信息
Oncologist. 2014 Feb;19(2):211. doi: 10.1634/theoncologist.2013-0410. Epub 2014 Jan 23.
Abstract
摘要
相似文献
1
Src inhibition is still a relevant target in pancreatic cancer.
Oncologist. 2014 Feb;19(2):211. doi: 10.1634/theoncologist.2013-0410. Epub 2014 Jan 23.
2
Phase II study of dasatinib (BMS-354825) in patients with metastatic adenocarcinoma of the pancreas.
Oncologist. 2013;18(10):1091-2. doi: 10.1634/theoncologist.2013-0255. Epub 2013 Sep 26.
3
Targeting the yin and the yang: combined inhibition of the tyrosine kinase c-Src and the tyrosine phosphatase SHP-2 disrupts pancreatic cancer signaling and biology in vitro and tumor formation in vivo.
Pancreas. 2013 Jul;42(5):795-806. doi: 10.1097/MPA.0b013e3182793fd7.
4
Therapeutic advances in metastatic pancreatic adenocarcinoma and related cancers: focus on evidence-based and sequenced approaches to survival extension in metastatic pancreatic adenocarcinoma.
Clin Adv Hematol Oncol. 2018 Sep;16 Suppl 17(9):1-16.
5
Identifying ideal candidates for nanoliposomal topoisomerase inhibitors in metastatic pancreatic adenocarcinoma.
Clin Adv Hematol Oncol. 2018 Sep;16 Suppl 17(9):9-10.
6
Unresectable adenocarcinoma of the pancreas.
Cancer Invest. 2000;18(4):406-7. doi: 10.3109/07357900009012185.
7
8
Identification and validation of phospho-SRC, a novel and potential pharmacodynamic biomarker for dasatinib (SPRYCEL), a multi-targeted kinase inhibitor.
Cancer Chemother Pharmacol. 2008 Nov;62(6):1065-74. doi: 10.1007/s00280-008-0699-5. Epub 2008 Feb 27.
9
Targeted inhibition of SRC kinase signaling attenuates pancreatic tumorigenesis.
Mol Cancer Ther. 2010 Aug;9(8):2322-32. doi: 10.1158/1535-7163.MCT-09-1212. Epub 2010 Aug 3.
10
Inhibition of the Hedgehog pathway induces autophagy in pancreatic ductal adenocarcinoma cells.
Oncol Rep. 2014 Feb;31(2):707-12. doi: 10.3892/or.2013.2881. Epub 2013 Nov 28.
引用本文的文献
1
Nuclear Functions of the Tyrosine Kinase Src.
Int J Mol Sci. 2020 Apr 11;21(8):2675. doi: 10.3390/ijms21082675.
2
Targeting the complexity of Src signalling in the tumour microenvironment of pancreatic cancer: from mechanism to therapy.
FEBS J. 2019 Sep;286(18):3510-3539. doi: 10.1111/febs.15011. Epub 2019 Aug 5.
3
Gjb4 serves as a novel biomarker for lung cancer and promotes metastasis and chemoresistance via Src activation.
Oncogene. 2019 Feb;38(6):822-837. doi: 10.1038/s41388-018-0471-1. Epub 2018 Sep 3.
4
CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma.
Nat Med. 2016 Mar;22(3):278-87. doi: 10.1038/nm.4038. Epub 2016 Feb 8.
5
A novel nuclear Src and p300 signaling axis controls migratory and invasive behavior in pancreatic cancer.
Oncotarget. 2016 Feb 9;7(6):7253-67. doi: 10.18632/oncotarget.6635.
6
Elucidation of the roles of the Src kinases in pancreatic acinar cell signaling.
J Cell Biochem. 2015 Jan;116(1):22-36. doi: 10.1002/jcb.24895.
本文引用的文献
1
Phase II study of dasatinib (BMS-354825) in patients with metastatic adenocarcinoma of the pancreas.
Oncologist. 2013;18(10):1091-2. doi: 10.1634/theoncologist.2013-0255. Epub 2013 Sep 26.
2
Biomedicine. Rare cancer successes spawn 'exceptional' research efforts.
Science. 2013 Apr 19;340(6130):263. doi: 10.1126/science.340.6130.263.
3
Nicotine induces inhibitor of differentiation-1 in a Src-dependent pathway promoting metastasis and chemoresistance in pancreatic adenocarcinoma.
Neoplasia. 2012 Dec;14(12):1102-14. doi: 10.1593/neo.121044.
4
Targeted inhibition of SRC kinase signaling attenuates pancreatic tumorigenesis.
Mol Cancer Ther. 2010 Aug;9(8):2322-32. doi: 10.1158/1535-7163.MCT-09-1212. Epub 2010 Aug 3.
5
Synergistic activity of the SRC family kinase inhibitor dasatinib and oxaliplatin in colon carcinoma cells is mediated by oxidative stress.
Cancer Res. 2009 May 1;69(9):3842-9. doi: 10.1158/0008-5472.CAN-08-2246. Epub 2009 Apr 21.
6
Inhibition of Src tyrosine kinase reverts chemoresistance toward 5-fluorouracil in human pancreatic carcinoma cells: an involvement of epidermal growth factor receptor signaling.
Oncogene. 2008 Dec 4;27(57):7212-22. doi: 10.1038/onc.2008.326. Epub 2008 Sep 15.
7
Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model.
Am J Pathol. 2006 Mar;168(3):962-72. doi: 10.2353/ajpath.2006.050570.
8
Inhibition of SRC tyrosine kinase as treatment for human pancreatic cancer growing orthotopically in nude mice.
Clin Cancer Res. 2004 Dec 1;10(23):8028-36. doi: 10.1158/1078-0432.CCR-04-0621.
9
Expression of kinase-defective mutants of c-Src in human metastatic colon cancer cells decreases Bcl-xL and increases oxaliplatin- and Fas-induced apoptosis.
J Biol Chem. 2004 Oct 29;279(44):46113-21. doi: 10.1074/jbc.M408550200. Epub 2004 Aug 23.
10
Inhibition of SRC tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cells.
Clin Cancer Res. 2004 Apr 1;10(7):2307-18. doi: 10.1158/1078-0432.ccr-1183-3.
Zotero 插件